A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 9, 2007, Pages 602-607

  Bruggers, Carol S ^a,b   Greene, Dayna ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Dose intensive; Low grade glioma; Sequential

Indexed keywords

ANTICONVULSIVE AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEASIBILITY STUDY; GLIOMA; HUMAN; INFECTION; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 34548454930     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318142b585     Document Type: Article

References (37)

1. Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia: Lippincott Williiams & Wilkins; 2002.
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3:255-268.
3. Phillip Pizzo DP. Principles and Practice of Pediatric Oncology. 4th ed. Philidelphia, New York: Lippencott-Raven; 2002.
4. VandenBerg SR, May EE, Rubinstein LJ, et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg. 1987;66:58-71.
5. Pollack IF, Claassen D, al-Shboul Q, et al. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg. 1995;82:536-547.
6. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol. 1997;15:2792-2799.
7. Berger MS, Deliganis AV, Dobbins J, et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 1994;74:1784-1791.
8. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer. 1995;75:1051-1059.
9. Listernick R, Charrow J, Greenwald M, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63-66.
10. Gururangan S, Cavazos CM, Ashley D, et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol. 2002;20:2951-2958.
11. Prados MD, Edwards MS, Rabbitt J, et al. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol. 1997;32:235-241.
12. Bruggers CS, Friedman HS, Phillips PC, et al. Leptomeningeal dissemination of optic pathway gliomas in three children. Am J Ophthalmol. 1991;111:719-723.
13. Pollack IF, Hurtt M, Pang D, et al. Dissemination of low grade intracranial astrocytomas in children. Cancer. 1994;73:2869-2878.
14. Hayostek CJ, Shaw EG, Scheithauer B, et al. Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer. 1993;72:856-869.
15. Shaw EG, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg. 1989;70:853-861.
16. Pierce SM, Barnes PD, Loeffler JS, et al. Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer. 1990;65:45-52.
17. Alvord EC Jr, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg. 1988;68:85-98.
18. North CA, North RB, Epstein JA, et al. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer. 1990;66:6-14.
19. Guthrie BL, Laws ER Jr. Supratentorial low-grade gliomas. Neurosurg Clin N Am. 1990;1:37-48.
20. Kovalic JJ, Grigsby PW, Shepard MJ, et al. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys. 1990;18:927-932.
21. Pons MA, Finlay JL, Walker RW, et al. Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol. 1992;14:151-158.
22. Castello MA, Schiavetti A, Padula A, et al. Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases. Med Pediatr Oncol. 1995;25:102-108.
23. McCowage G, Tien R, McLendon R, et al. Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol. 1996;2 7:32-39.
24. Massimino M, Spreafico F, Cefalo G, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol. 2002;20:4209-4216.
25. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997;85:747-754.
26. Bonadonna G, Zambetti M, Valagussa P. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA. 1995;273:542-547.
27. Vigani A, Pensa F, Vaira F, et al. Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer. Anticancer Res. 2000;20:4015-4018.
28. Hudis C, Seidman A, Raptis G, et al. Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience. Semin Oncol. 1996;23(1 suppl 1):58-64.
29. Hudis C, Seidman A, Baselga J, et al. Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. J Clin Oncol. 1999;17:93-100.
30. Norton L. Evolving concepts in the systemic drug therapy of breast cancer. Semin Oncol. 1997;24(4 suppl 10):S10-S13.
31. Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med. 1981;304:10-15.
32. Kadota RP, Kun LE, Langston JW, et al. Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study. J Pediatr Hematol Oncol. 1999;21:198-202.
33. Strojan P, Petric-Grabnar G, Zupancic N, et al. Concomitant chemoradiotherapy for incompletely resected supratentorial low-grade astrocytoma in children: preliminary report. Med Pediatr Oncol. 1999;32:112-116.
34. Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmatic/ hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988;23:79-85.
35. Castello MA, Schiavetti A, Varrasso G, et al. Chemotherapy in low-grade astrocytoma management. Childs Nerv Syst. 1998;14:6-9.
36. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol. 1995;13:2072-2076.
37. Quinn JA, Reardon DA, Friedman AH, et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol. 2003;21:646-651.